News

Alexis Ellington has a renewed outlook on life after being the first Saint Luke's patient to receive a new cancer treatment called Bispecific T-cell Engagers therapy, or BiTE.

We are talking about lung cancer and how precision oncology helps patients diagnosed with the disease with treatment.